Literature DB >> 194678

The concept of minimal breast cancer and the pathologist's role in the diagnosis of "early carcinoma".

L V Ackerman, A L Katzenstein.   

Abstract

Minimal breast cancer has been variously defined as a lesion 1 cm or less, or even 5 mm or less. Some authorities consider intraductal cancer and lobular carcinoma in situ as minimal, but we believe that these should be excluded from consideration. Minimal cancer is not early cancer inasmuch as a 1 cm lesion represents 30 doubling times, and a certain percentage of these small cancers have already disseminated. The pathologist's responsibility in diagnosing minimal cancer has become more difficult. His problem is in three major areas: Is this proliferative cystic lesion cancer? Is this lobular or intraductal proliferative lesion in situ carcinoma? And if so, he must be concerned also with the treatment as well as the diagnosis. In any screening program, these minimal cancers, either invasive or in situ, should be evaluated by a group of experts in order that the program be entirely accurate.

Entities:  

Mesh:

Year:  1977        PMID: 194678     DOI: 10.1002/1097-0142(197706)39:6<2755::aid-cncr2820390663>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment.

Authors:  P P Rosen; R Senie; D Schottenfeld; R Ashikari
Journal:  Ann Surg       Date:  1979-03       Impact factor: 12.969

Review 2.  Clinical decision-making in early breast cancer.

Authors:  C M Balch; S E Singletary; K I Bland
Journal:  Ann Surg       Date:  1993-03       Impact factor: 12.969

3.  Minimal breast cancer: evaluation of histology and biological marker expression.

Authors:  E A Dublin; R R Millis; P Smith; L G Bobrow
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

Review 4.  Clinical characteristics of breast ductal carcinoma in situ with microinvasion: a narrative review.

Authors:  Jie Zheng; Jingjing Yu; Tao Zhou
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.